Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes

Biochemical Pharmacology

Volumn 58, Issue 7, 1999, Pages 1201-1208

  Nadin, Louise ^a   Murray, Michael ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

All trans retinoic acid; Cytochrome P450; Human hepatic microsomes; Oxidative biotransformation; Retinoid 4 hydroxylation

Indexed keywords

7 ETHOXYCOUMARIN; CYCLOPHOSPHAMIDE; CYTOCHROME P450; DICLOFENAC; KETOCONAZOLE; LAURIC ACID; PACLITAXEL; PARATHION; QUINIDINE; RETINOIC ACID; SULFAPHENAZOLE; TOLBUTAMIDE; TORASEMIDE; TROLEANDOMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG OXIDATION; HUMAN; HUMAN TISSUE; LIVER MICROSOME; PRIORITY JOURNAL;

CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; HUMANS; HYDROXYLATION; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; TRETINOIN;

EID: 0033213785     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00192-6     Document Type: Article

References (40)

1. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
2. Castaigne S., Chomienne C., Daniel M.T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 76:1990;1704-1709.
3. Trump D.L. Retinoids in bladder, testis and prostate cancer Epidemiologic, pre-clinical and clinical observations . Leukemia. 8:1994;S50-S54.
4. Muindi J.F., Frankel S.R., Miller W.H. Jr, Jakubowski A., Scheinberg D.A., Young C.W., Dmitrovsky E., Warrell R.P. Jr. Continuous treatment with all-trans-retinoic acid causes a progressive reduction in plasma drug concentrations Implications for relapse and retinoid resistance in patients with acute promyelocytic leukemia . Blood. 79:1992;299-303.
5. Muindi J., Frankel S.R., Huselton C., DeGrazia F., Garland W.A., Young C.W., Warrell R.P. Jr. Clinical pharmacology of all-trans-retinoic acid in patients with acute promyelocytic leukemia. Cancer Res. 52:1992;2138-2142.
6. Roberts A.B., Lamb L.C., Sporn M.B. Metabolism of all-trans-retinoic acid in hamster liver microsomes Oxidation of 4-hydroxy to 4-keto-retinoic acid . Arch Biochem Biophys. 199:1979;374-383.
7. Van Wauwe J.P., Coene M.-C., Goossens J., Cools W., Monbaliu J. Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats. J Pharmacol Exp Ther. 252:1990;365-369.
8. Nadin L., Murray M. All-trans-retinoic acid 4-hydroxylation in human liver microsomes In vitro modulation by therapeutic retinoids . Br J Clin Pharmacol. 41:1996;609-612.
9. Leo M.A., Lasker J.M., Raucy J.L., Kim C.-I., Black M., Lieber C.S. Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch Biochem Biophys. 269:1989;305-312.
10. Muindi J.F., Young C.W. Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans-retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P450 isoforms. Cancer Res. 53:1993;1226-1229.
11. Martini R., Murray M. Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation. Arch Biochem Biophys. 303:1993;57-66.
12. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
13. Kochhar D.M., Penner J.D., Satre M.A. Derivation of retinoic acid and metabolites from a teratogenic dose of retinol (vitamin A) in mice. Toxicol Appl Pharmacol. 96:1988;429-441.
14. Prough R.A., Burke M.D., Mayer R.T. Direct fluorometric methods for measuring mixed function oxidase activity. Methods Enzymol. 52:1978;372-377.
15. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J. 55:1953;416-421.
16. Knodell R.G., Hall S.D., Wilkinson G.R., Guengerich F.P. Hepatic metabolism of tolbutamide Characterization of the form of cytochrome P-450 involved in the methyl hydroxylation and relationship to in vivo disposition . J Pharmacol Exp Ther. 241:1987;1112-1119.
17. Romano M.C., Straub K.M., Yodis L.A., Eckardt R.D., Newton J.F. Determination of microsomal lauric acid hydroxylase activity by HPLC with flow-through radiochemical quantitation. Anal Biochem. 170:1988;83-93.
18. Okita R.T., Clark J.E., Okita J.R., Masters B.S.S. ω- and (ω-1)-Hydroxylation of eicosanoids and fatty acids by high-performance liquid chromatograpy. Methods Enzymol. 206:1991;432-441.
19. Omura T., Sato R. The carbon-monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem. 253:1964;828-832.
20. Williams C.H., Kamin H. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem. 237:1962;187-194.
21. UT-A, in rats with portal bypass. Relevance to estradiol accumulation and impaired drug metabolism in hepatic cirrhosis. J Clin Invest. 83:1989;1211-1216.
22. Murray M. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats. Arch Biochem Biophys. 262:1988;381-388.
23. Butler A.M., Murray M. Biotransformation of parathion in human liver Participation of CYP3A4 and its inactivation during microsomal parathion oxidation . J Pharmacol Exp Ther. 280:1997;966-973.
24. Sutton D., Nadin L., Butler A.M., Murray M. Role of CYP3A4 in human hepatic diltiazem N-demethylation. Inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J Pharmacol Exp Ther. 282:1997;294-300.
25. Chang T.K.H., Weber G.F., Crespi C.L., Waxman D.J. Differential activation of cyclophosphamide and ifosfamide by cytochrome-P450-B and cytochrome-P450-3A in human liver microsomes. Cancer Res. 53:1993;5629-5637.
26. Rahman A., Korzekwa K.R., Grogan J., Gonzalez F.J., Harris J.W. Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8. Cancer Res. 54:1994;5543-5546.
27. Leemann T., Transon C., Dayer P. Cytochrome P450tb (CYP2C), A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver. Life Sci. 52:1993;29-34.
28. Miners J.O., Smith K.J., Robson R.A., McManus M.E., Veronese M.E., Birkett D.J. Tolbutamide hydroxylation by human liver microsomes Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations . Biochem Pharmacol. 37:1988;1137-1144.
29. Miners J.O., Rees D.L., Valente L., Veronese M.E., Birkett D.J. Human hepatic P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism. J Pharmacol Exp Ther. 272:1995;1076-1081.
30. Relling M.V., Aoyama T., Gonzalez F.J., Meyer U.A. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. J Pharmacol Exp Ther. 252:1990;442-447.
31. Jurima-Romet M., Neigh S., Casley W.L. Induction of cytochrome P450 3A by retinoids in rat hepatocyte culture. Hum Exp Toxicol. 16:1997;198-203.
32. Ray W.J., Bain G., Yao M., Gottleib D.I. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem. 272:1997;18702-18708.
33. White J.A., Guo Y.-D., Baetz K., Beckett-Jones B., Bonasoro J., Hsu K.E., Dilworth F.J., Jones G., Petkovich M. Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J Biol Chem. 271:1996;29922-29927.
34. White J.A., Beckett-Jones B., Guo Y.-D., Dilworth F.J., Bonasoro J., Jones G., Petkovich M. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450 (CYP26). J Biol Chem. 272:1997;18538-18541.
35. Duell E.A., Kang S., Voorhees J.J. Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid J Invest Dermatol. 106:1996;316-320.
36. Han I.S., Choi J.-H. Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells. J Clin Endocrinol Metab. 81:1996;2069-2075.
37. Guengerich F.P. Human cytochrome P450 enzymes. Ortiz de Montellano P.R. Cytochrome P450 Structure, Mechanism and Biochemistry . 1995;473-535 Plenum Press, New York.
38. Rigas J.R., Francis P.A., Muindi J.R.F., Kris M.G., Huselton C., DeGrazia F., Orazem J.P., Young C.W., Warrell R.P. Jr. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. J Natl Cancer Inst. 85:1993;1921-1926.
39. Jacolot F., Simon I., Dreano Y., Beaune P., Riche C., Berthou F. Identification of the cytochrome P-450IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem Pharmacol. 41:1991;1911-1919.
40. Miller V.A., Rigas J.R., Muindi J.R.F., Tong W.P., Venkatraman E., Kris M.G., Warrell R.P. Jr. Modulation of all-trans-retinoic acid pharmacokinetics by liarozole. Cancer Chemother Pharmacol. 34:1994;522-526.